Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Hyperimmune Intravenous Immunoglobulin Treatment for Severe H1N1 2009 Infection

NCT01617317 is registered in ClinicalTrials.gov with The University of Hong Kong as lead sponsor.

NCT NCT01617317
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01617317 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Hyperimmune Intravenous Immunoglobulin Treatment for Severe H1N1 2009 Infection
Lead sponsor
The University of Hong Kong
Phase
Not applicable
Overall status
Completed
Start date
January 31, 2010
Completion date
May 31, 2012
Enrollment
34 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

novel 2009 influenza a (h1n1) infection